Encompass Health (EHC) Stock Price
Encompass Health Price
Over the last 19 years Encompass Health grew revenue by 6.8% annually, reaching 5.94 B USD. Earnings per share have declined at 2.2% per year over the last 18 years. For Encompass Health, the net margin of 9.5% is broadly stable versus 10.3% a few years ago. At today's price the dividend yield works out to roughly 0.57%. The payout ratio is around 13% of earnings. The dividend has grown at 5.7% per year over the past 12 years. The consensus 12-month price target for Encompass Health is 142.80 USD, about 17.3% above where the stock trades today. Of 16 analysts, 15 rate the stock a buy — an overall Buy consensus. The stock trades about 30% above its 52-week low.
Encompass Health stock price
Details
Stock Price
ⓘHow to Read This Chart
This chart tracks the historical stock price of Encompass Health over time. You can switch between daily, weekly, and monthly views and select custom time ranges — from a single day to the full available history. Use the toggle to view price changes in absolute currency terms or as a percentage change relative to the starting date.
Total Return vs. Price Return
The "Total Return" toggle includes reinvested dividends on top of the pure price movement. This is critical because dividends can account for a significant portion of long-term returns. Historically, roughly 40 % of the S&P 500's total return has come from dividends. Always compare total return when evaluating a stock's real performance against a benchmark.
Intraday Price Data
When viewing a one-day time frame, the chart displays real-time intraday price movements. This is useful for observing how Encompass Health stock reacts to market openings, earnings releases, or breaking news throughout the trading session.
What to Look For
Look for long-term trends (sustained upward or downward movements over months and years), support and resistance levels (price zones where the stock repeatedly bounces or reverses), and volatility (how much the price fluctuates day to day). Comparing Encompass Health's price chart to a market index like the S&P 500 can reveal whether the stock is outperforming or underperforming the broader market.
| Date | Encompass Health Price |
|---|---|
| 9/4/2026 | 121.79 USD |
| 9/3/2026 | 122.59 USD |
| 9/2/2026 | 121.18 USD |
| 9/1/2026 | 122.05 USD |
| 8/31/2026 | 121.26 USD |
| 8/28/2026 | 120.81 USD |
| 8/27/2026 | 119.35 USD |
| 8/26/2026 | 120.78 USD |
| 8/25/2026 | 120.14 USD |
| 8/24/2026 | 121.60 USD |
| 8/21/2026 | 120.31 USD |
| 8/20/2026 | 120.91 USD |
| 8/19/2026 | 122.30 USD |
| 8/18/2026 | 123.39 USD |
| 8/14/2026 | 123.59 USD |
| 8/13/2026 | 123.55 USD |
| 8/12/2026 | 124.83 USD |
| 8/11/2026 | 125.35 USD |
| 8/10/2026 | 125.16 USD |
| 8/7/2026 | 125.23 USD |
| 8/6/2026 | 124.82 USD |
| 8/5/2026 | 111.42 USD |
| 8/4/2026 | 110.22 USD |
| 8/3/2026 | 112.47 USD |
| 7/31/2026 | 111.07 USD |
| 7/30/2026 | 110.89 USD |
| 7/29/2026 | 114.96 USD |
| 7/27/2026 | 114.61 USD |
| 7/23/2026 | 111.06 USD |
| 7/22/2026 | 111.02 USD |
Encompass Health Revenue, EBIT, Net Income
3 Years
5 Years
10 Years
25 Years
Max
Details
Encompass Health Income Statement, Balance Sheet, Cash Flow Statement
| REVENUEB USD |
|---|
| REVENUE GROWTH% |
| GROSS MARGIN% |
| GROSS INCOMEB USD |
| EBITB USD |
| EBIT MARGIN% |
| NET INCOMEM USD |
| NET INCOME GROWTH% |
| DIVIDENDDIV.USD |
| DIVIDEND GROWTHDIV. GROWTH% |
| SHARESM |
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026e | 2027e | 2028e | 2029e | 2030e |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 3.12 | 3.64 | 3.91 | 4.28 | 4.61 | 3.57 | 4.01 | 4.35 | 4.80 | 5.37 | 5.94 | 6.46 | 6.99 | 7.56 | 8.27 | 8.99 |
| 31.21 | 16.92 | 7.44 | 9.30 | 7.67 | -22.56 | 12.56 | 8.32 | 10.42 | 11.91 | 10.46 | 8.85 | 8.27 | 8.11 | 9.39 | 8.66 |
| 95.89 | 96.16 | 96.19 | 96.28 | 96.35 | 95.20 | 42.43 | 40.32 | 41.28 | 41.56 | 95.70 | 95.70 | 95.70 | 95.70 | 95.70 | 95.70 |
| 2.99 | 3.50 | 3.76 | 4.12 | 4.44 | 3.40 | 1.70 | 1.75 | 1.98 | 2.23 | 5.68 | 6.18 | 6.69 | 7.24 | 7.92 | 8.60 |
| 0.55 | 0.65 | 0.65 | 0.68 | 0.69 | 0.66 | 0.66 | 0.63 | 0.75 | 0.86 | 1.18 | 1.10 | 1.19 | 1.27 | 1.48 | 1.61 |
| 17.78 | 17.79 | 16.59 | 15.92 | 15.03 | 18.54 | 16.42 | 14.49 | 15.68 | 16.08 | 19.81 | 17.00 | 16.94 | 16.77 | 17.92 | 17.95 |
| 183.00 | 247.00 | 271.00 | 292.00 | 358.00 | 284.00 | 412.00 | 271.00 | 352.00 | 455.00 | 566.00 | 624.00 | 682.00 | 743.00 | 862.00 | 946.00 |
| -17.57 | 34.97 | 9.72 | 7.75 | 22.60 | -20.67 | 45.07 | -34.22 | 29.89 | 29.26 | 24.40 | 10.25 | 9.29 | 8.94 | 16.02 | 9.74 |
| 1.11 | 0.94 | 0.98 | 1.04 | 1.10 | 1.12 | 1.12 | 0.86 | 0.60 | 0.47 | 0.70 | 0.76 | 0.76 | 0.76 | – | – |
| 42.31 | -15.32 | 4.26 | 6.12 | 5.77 | 1.82 | – | -23.21 | -30.23 | -21.67 | 48.94 | 8.57 | – | – | – | – |
| 100.60 | 99.20 | 99.20 | 100.00 | 99.50 | 100.10 | 100.20 | 100.80 | 101.50 | 102.30 | 102.00 | 102.00 | 102.00 | 102.00 | 102.00 | 102.00 |
Details
Income Statement Key Figures
ⓘRevenue and Revenue Growth
Revenue is the starting point of every income statement — it measures the total sales Encompass Health generates from its core business. Revenue growth (expressed as year-over-year percentage change) is one of the most important indicators of business momentum. Sustained growth above 10 % annually is generally considered strong, while declining revenue is a serious warning sign that demands investigation.
Gross Margin
Gross margin = (Revenue − Cost of Goods Sold) ÷ Revenue. It reveals what percentage of each dollar of revenue Encompass Health retains after direct production costs. High gross margins (above 50 %) are typical of asset-light businesses like software and brands, while capital-intensive industries like manufacturing often operate below 30 %. Compare Encompass Health's gross margin to industry peers and track it over time to spot improving or deteriorating pricing power.
EBIT and EBIT Margin
EBIT measures operating profit — what remains after subtracting all operating expenses (including R&D, sales, and administrative costs) from gross profit. The EBIT margin shows this as a percentage of revenue. Because it excludes interest and taxes, EBIT allows fair comparisons between companies with different debt levels and tax jurisdictions. A rising EBIT margin indicates improving operational efficiency.
Net Income and Earnings Per Share (EPS)
Net income is the company's final profit after all expenses, interest, and taxes. Dividing net income by the number of shares outstanding gives you EPS — the single most influential metric in stock valuation. Consistent EPS growth is the primary driver of long-term stock price appreciation. Always check whether EPS growth comes from genuine profit improvement or from share buybacks reducing the share count.
Shares Outstanding
The total number of shares Encompass Health has issued. A declining share count (through buybacks) boosts EPS and signals management confidence. A rising share count (through stock issuance) dilutes existing shareholders. Always monitor this number alongside EPS to get the full picture of per-share value creation.
Analyst Estimates
The projected figures represent consensus estimates from professional analysts. Compare these forecasts against Encompass Health's historical growth rates to assess whether expectations are realistic. A company that consistently beats consensus estimates tends to see its stock price rewarded over time, while repeated misses erode investor confidence.
Encompass Health stock margins
3 Years
5 Years
10 Years
25 Years
Max
Details
Encompass Health Stock Revenue, EBIT, Earnings per Share
3 Years
5 Years
10 Years
25 Years
Max
Details
Encompass Health business model & stock analysis
Encompass Health SWOT Analysis
Strengths
1. Strong market presence: Encompass Health Corp has a solid position in the healthcare industry, offering a wide range of services in various geographical locations.
2. Established brand reputation: The company is known for its high-quality healthcare services and is trusted by patients and medical professionals alike.
3. Diverse service portfolio: Encompass Health Corp offers comprehensive services including rehabilitation, home health, and hospice care, allowing them to cater to different healthcare needs.
Weaknesses
1. Dependency on government regulations: Changes in healthcare policies and reimbursement guidelines put Encompass Health Corp at risk, as they heavily rely on government funding.
2. Limited international presence: The company operates primarily within the United States, which may limit potential growth opportunities in international markets.
3. Vulnerability to legal and regulatory challenges: Any legal or regulatory issues faced by the company could significantly impact its operations and financial performance.
Opportunities
1. Aging population and increasing healthcare needs: Encompass Health Corp can leverage the growing demand for healthcare services due to the aging population, by expanding its service offerings and targeting specific healthcare needs.
2. Technological advancements: Implementing innovative technologies and digital solutions can enhance operational efficiency, improve patient care, and attract tech-savvy consumers.
3. Potential for mergers and acquisitions: The company can explore strategic partnerships, mergers, or acquisitions to expand its geographic reach, diversify services, and gain a competitive edge.
Threats
1. Intense competition: Encompass Health Corp faces competition from other healthcare providers, including hospitals, clinics, and specialized service providers, which may limit its market share.
2. Economic downturns and healthcare cost pressures: During economic downturns or when healthcare costs become a burden for consumers, Encompass Health Corp may face challenges in maintaining profitability.
3. Regulatory changes and compliance costs: Frequent changes in regulations and increased compliance costs can negatively impact the company's financial performance and operational efficiency.
Encompass Health Employees
3 Years
5 Years
10 Years
25 Years
Max
Details
Encompass Health Segments
Encompass Health Revenue by Segment (1/2)
Max
Details
Encompass Health Revenue by Segment (2/2)
3 Years
5 Years
Max
Details
Encompass Health Eulerpool Fair Value
Details
Fair Value Estimate
ⓘWhat Is Fair Value?
Fair value is an estimate of what a stock is truly "worth" based on its financial fundamentals, independent of the current market price. If the calculated fair value is above the current share price, the stock may be undervalued — and vice versa. This chart shows three different fair value approaches so you can cross-check them against each other.
Earnings-Based Fair Value
Calculated by multiplying the current earnings per share (EPS) by the average historical P/E ratio over a selected multi-year period. The smoothing over several years filters out temporary spikes or dips. If this fair value exceeds the market price, it suggests the stock is cheap relative to its earning power.
Example: Fair Value (Earnings) 2022 = EPS 2022 × Average P/E 2019–2021
Revenue-Based Fair Value
Derived by multiplying revenue per share by the average historical price-to-sales ratio. This method is particularly useful for companies with volatile or temporarily depressed earnings, as revenue tends to be more stable than profits. It answers: "At what price has the market historically valued each dollar of this company's sales?"
Example: Fair Value (Revenue) 2022 = Revenue per Share 2022 × Average P/S 2019–2021
Dividend-Based Fair Value
Calculated by dividing the dividend per share by the average historical dividend yield. This approach is most relevant for mature, consistently dividend-paying companies. If the resulting fair value is higher than the current price, it implies the stock offers a better yield than its historical average.
Example: Fair Value (Dividend) 2022 = Dividend per Share 2022 ÷ Average Yield 2019–2021
How to Use This Chart
When all three fair value lines converge above the current price, it strengthens the case that the stock is undervalued. When they diverge, investigate why — it may indicate a structural shift in margins, payout policy, or growth rate. The forward estimates on the right extend the analysis using projected fundamentals, helping you assess whether the current price already reflects future growth expectations.
Encompass Health historical P/E ratio, EBIT multiple, and P/S ratio
Encompass Health annual returns
Details
Annual Return
ⓘWhat This Chart Shows
This chart breaks down 's total annual return into two components: price return (gains or losses from stock price movement) and dividend return (income received from dividend payments). Together, they represent the total return an investor would have earned in each calendar year.
Price Return
Price return measures the percentage change in 's stock price from January 1st to December 31st of each year. Positive bars indicate the stock appreciated; negative bars show a decline. This is the component most investors focus on, but it tells only part of the story — especially for dividend-paying stocks.
Dividend Return
Dividend return represents the income generated from dividends paid during the year, expressed as a percentage of the starting stock price. While it may seem small in any single year (typically 1–4 % for established companies), dividends compound significantly over decades and have historically contributed roughly 40 % of total stock market returns.
What to Look For
Examine how many years showed positive vs. negative returns to gauge consistency. A stock with mostly positive years and small drawdowns suggests lower risk. Also compare 's annual returns to a benchmark index — consistently outperforming the market is a hallmark of a strong investment. Pay attention to the worst years: understanding downside risk is just as important as chasing upside potential.
Encompass Health shares outstanding
3 Years
5 Years
10 Years
25 Years
Max
Details
Encompass Health stock splits
Encompass Health Dividend History
14 years of dividend payments
Encompass Health dividend history and estimates
Max
Details
Encompass Health dividend payout ratio
3 Years
5 Years
10 Years
25 Years
Max
Details
Current Encompass Health forecasts and price targets in September 2026
Analyst Price Targets 2026Encompass Health Analyst Rating Actions
| Date | Firm | Action | Rating | Reliability |
|---|---|---|---|---|
| 8/10/2026 | Maintained | Buy | 60 | |
| 8/7/2026 | Maintained | Buy | 46 | |
| 8/7/2026 | Maintained | Buy | – | |
| 8/6/2026 | Maintained | Overweight | 57 | |
| 5/5/2026 | Maintained | Overweight | 57 | |
| 2/6/2026 | Maintained | Overweight | 57 | |
| 10/30/2025 | Maintained | Overweight | 57 | |
| 10/2/2025 | Maintained | Buy | 46 | |
| 9/16/2025 | Maintained | Overweight | 43 | |
| 9/10/2025 | Maintained | Buy | 64 |
Eulerpool Reliability Score (0–100): measures how often a firm’s bullish or bearish calls were directionally correct three months later, blended with the average return following its calls. Every rating we record is stored permanently and scores update continuously; firms with fewer than 3 measured calls are not scored yet.
Encompass Health Earnings Calls
Encompass Health Earnings Estimates & Surprises
| Date | EPS estimate | EPS Actual | Revenue Estimate | Price reaction | Quarterly report |
|---|---|---|---|---|---|
| 8/5/2026 | 1.50USD | - | 1.59 BUSD | - | 2026 Q2 |
| 4/30/2026 | 1.51USD | - | 1.59 BUSD | - | 2026 Q1 |
| 2/5/2026 | 1.31USD | - | 1.56 BUSD | - | 2025 Q4 |
| 4/25/2024 | 0.92USD | - | 1.27 BUSD | - | 2024 Q1 |
| 2/5/2024 | 0.82USD | - | 1.25 BUSD | - | 2023 Q4 |
| 7/31/2023 | 0.78USD | - | 1.17 BUSD | - | 2023 Q2 |
| 4/25/2023 | 0.77USD | - | 1.16 BUSD | - | 2023 Q1 |
| 1/30/2023 | 0.84USD | - | 1.14 BUSD | - | 2022 Q4 |
| 10/26/2022 | 0.64USD | - | 1.08 BUSD | - | 2022 Q3 |
| 8/1/2022 | 0.98USD | - | 1.36 BUSD | - | 2022 Q2 |
EESG©
Eulerpool ESG Scorecard© for the Encompass Health stock
EEnvironment
20
Environment
SSocial
20
Social
GGovernance (Corporate Governance)
4
Governance (Corporate Governance)
The Eulerpool ESG Scorecard© is the strictly copyrighted intellectual property of Eulerpool Research Systems. Any unauthorized use, imitation, or infringement will be actively pursued and may lead to significant legal consequences. For licenses, collaborations, or usage rights, please contact us directly via our contact form. Contact Form to us.
Encompass Health shareholder structure
| % | Name |
|---|---|
10.53690% | |
4.85278% | |
4.50152% | |
4.37009% | |
3.76600% | |
3.31321% |
Encompass Health Beneficial Ownership Filings (SEC 13D/G)
| Stake | Holder | Filing |
|---|---|---|
21.50% | SEC ↗ | |
10.30% | SEC ↗ | |
10.30% | SEC ↗ | |
10.30% | SEC ↗ | |
10.30% | SEC ↗ | |
10.30% | SEC ↗ | |
10.00% | SEC ↗ | |
9.54% | SEC ↗ | |
9.54% | SEC ↗ | |
9.50% | SEC ↗ |
Encompass Health Executives and Management Board
15 members · avg. age 61 · 27 % women
Mr. Mark Tarr (63)
President, Chief Executive Officer, Director · since 2004
9.30 M USD
Management
Mr. Douglas Coltharp (64)
Chief Financial Officer, Executive Vice President
Mr. Patrick Darby (60)
Executive Vice President, General Counsel, Secretary
Dr. Elissa Charbonneau (65)
Chief Medical Officer
Mr. Andrew Price (58)
Chief Accounting Officer · since 2012
Mr. Edmund Fay (58)
Senior Vice President, Treasurer · since 2008
Mr. Patrick Tuer (41)
Chief Operating Officer, Executive Vice President
Board of Directors
Mr. Gregory Carmichael (63)
Independent Director
Ms. Leslye Katz (70)
Independent Director
Mr. Christopher Reidy (68)
Independent Director
Ms. Joan Herman (71)
Independent Director
Ms. Nancy Schlichting (70)
Independent Director
Mr. Terrance Williams (56)
Independent Director
Encompass Health Supply Chain
Encompass Health Supply Chain
Correlation: how closely stock prices move together
| # | Name | Trend | |||
|---|---|---|---|---|---|
| 1 | 0.43 | -0.33 | -0.19 | ||
| 2 | -0.08 | -0.37 | -0.18 |
Frequently asked questions about Encompass Health
Encompass Health Corp operates as a leading integrated healthcare services provider. The company's business model primarily focuses on offering post-acute healthcare services and rehabilitation therapies. With a network of inpatient rehabilitation hospitals, home health agencies, and hospice agencies, Encompass Health aims to provide high-quality, personalized care to patients recovering from illnesses, injuries, or surgeries. Through its interdisciplinary approach, advanced technologies, and clinical expertise, Encompass Health Corp strives to improve patients' health outcomes and enhance their overall quality of life.
Encompass Health Corp is primarily active in the healthcare industry.
Encompass Health Corp faces competition from various companies in the market. Some of its main competitors include Kindred Healthcare, Select Medical Holdings Corporation, and HealthSouth Corporation.
Encompass Health Corp, formerly known as HealthSouth Corporation, is a leading provider of integrated healthcare services in the United States. Founded in 1984, the company has a rich history and a strong background in rehabilitation and home health services. Encompass Health Corp offers a wide range of services, including inpatient rehabilitation, outpatient care, and home health services across various settings. With a commitment to delivering high-quality care and improving patients' lives, Encompass Health Corp has grown to become one of the largest post-acute healthcare providers in the country, serving thousands of patients annually. The company's dedication to innovation and excellence has earned it a solid reputation in the healthcare industry.
Encompass Health Corp has achieved several significant milestones over the years. Firstly, the company expanded its operations and became the leading provider of integrated post-acute healthcare services in the United States. Furthermore, they successfully rebranded their name from HealthSouth Corporation to Encompass Health Corp in 2018, showcasing their commitment to comprehensive and innovative care. Encompass Health Corp has consistently ranked among Fortune 500 companies and has received recognition for its quality patient care and clinical outcomes. Additionally, the company continues to grow its network of hospitals, home health agencies, and hospice centers, ensuring a broad range of services to meet patients' evolving needs.
Encompass Health Corp is primarily present in the United States.
Encompass Health Corp represents a strong emphasis on patient-centered care and providing high-quality, compassionate healthcare services. The company's values revolve around integrity, excellence, collaboration, and compassion. Encompass Health Corp is dedicated to delivering innovative healthcare solutions and improving the lives of patients through personalized care plans and advanced medical technologies. With a focus on positive patient outcomes, the company strives to continually enhance its services, expand its reach, and contribute positively to the communities it serves. Encompass Health Corp's corporate philosophy centers on delivering exceptional care with a commitment to clinical excellence, integrity, and respect for individuals.
Analysts currently set an average price target of 143.14 USD for the Encompass Health stock (median: 142.80 USD), implying +17.5 % versus the latest price. The consensus is based on 16 analyst ratings.
16 analysts currently rate the Encompass Health stock: 15 recommend buying, 1 holding and 0 selling. For 2026, analysts expect Encompass Health to generate revenue of 6.46 B USD and earnings per share of 6.13 USD.
Converted at the current exchange rate, the Encompass Health share trades at 104.88 EUR (121.79 USD).
The Encompass Health share (EHC) is listed on 2 stock exchanges, including: NYSE (EHC), Frankfurt (HSOA.F).
Encompass Health Corp is a leading provider of rehabilitation services in the United States. The company operates 140 hospitals, rehabilitation centers, and home health services in 39 states, serving millions of patients annually. The company's business model focuses on offering a comprehensive range of rehabilitation services, including hospital rehabilitation, in-patient rehabilitation, in-home healthcare, and long-term care. Encompass Health's services aim to restore patients' independence and mobility, improving their quality of life. The company offers a wide range of treatments, including therapy, rehabilitation, and nursing care, and utilizes modern technologies such as robots to assist patients. Collaboration with insurance companies and government agencies is an important part of Encompass Health's business model, enabling the company to provide its services and expand access to healthcare for a broader population. In addition, the company offers specialized rehabilitation programs for patients with brain injuries, spinal cord injuries, strokes, and other neurological disorders. Encompass Health also sells medical equipment and accessories and provides electronic patient documentation and billing systems to other healthcare facilities. The company's success is attributed to its focus on a crucial niche in the healthcare industry and the increasing demand for rehabilitation services due to an aging population and the need for support after accidents and illnesses. By utilizing modern technology to achieve medical advancements and providing value-based care, Encompass Health is able to offer high-quality services to patients while maintaining a profitable business model. In summary, Encompass Health's business model is centered around providing comprehensive and coordinated rehabilitation services to patients. The company's use of modern technology and partnerships with insurance companies and government agencies are key to its success. The company is well-positioned to meet the demands of the growing rehabilitation market and expand its market share.
The expected revenue of Encompass Health is 6.46 B USD. This figure is based on current financial data and reflects the company's business performance.
The expected profit of Encompass Health is 624.76 M USD. The net profit reflects the company's profitability after deducting all expenses.
The price-to-earnings ratio (P/E) of Encompass Health is currently 19.88. The P/E ratio compares the current share price to the earnings per share and helps investors assess the valuation of the Encompass Health stock.
The price-to-sales ratio (P/S) of Encompass Health is currently 1.92. The P/S ratio compares the market capitalization to the annual revenue and serves as a valuation metric for the Encompass Health stock.
The Eulerpool Quality Score for Encompass Health is 8/10.
The ISIN of Encompass Health is US29261A1007. The ISIN (International Securities Identification Number) is a globally unique identifier for securities.
The WKN of Encompass Health is A2H9HM. The WKN (Wertpapierkennnummer) is a six-digit German security identification number.
The ticker of Encompass Health is EHC. The ticker symbol is used to trade Encompass Health shares on the stock exchange.
Over the past 12 months, Encompass Health paid a dividend of 0.70 USD . This corresponds to a dividend yield of about 0.57 %. For the coming 12 months, Encompass Health is expected to pay a dividend of 0.76 USD.
The current dividend yield of Encompass Health is 0.57 %.
Encompass Health pays a dividend, distributed in the months of , , , .
Encompass Health paid dividends every year for the past 13 years.
For the upcoming 12 months, dividends amounting to 0.76 USD are expected. This corresponds to a dividend yield of 0.62 %.
Encompass Health is assigned to the 'Health' sector.
In the year 2025, Encompass Health distributed 0.64 USD as dividends.
The dividends of Encompass Health are distributed in USD.
Encompass Health stock
Encompass Health Peer Group
Encompass Health Ticker
Encompass Health FIGI
All fundamentals and in-depth analysis of Encompass Health
Our stock analysis for Encompass Health stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Encompass Health. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.